Page last updated: 2024-09-05

sb 203580 and kr 31378

sb 203580 has been researched along with kr 31378 in 1 studies

Compound Research Comparison

Studies
(sb 203580)
Trials
(sb 203580)
Recent Studies (post-2010)
(sb 203580)
Studies
(kr 31378)
Trials
(kr 31378)
Recent Studies (post-2010) (kr 31378)
3,48941,1372000

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jung, YS; Kim, E; Lee, DH; Lim, H; Yi, KY; Yoo, SE1

Other Studies

1 other study(ies) available for sb 203580 and kr 31378

ArticleYear
KR-31378 protects cardiac H9c2 cells from chemical hypoxia-induced cell death via inhibition of JNK/p38 MAPK activation.
    The Japanese journal of physiology, 2004, Volume: 54, Issue:6

    Topics: Animals; Anthracenes; Butadienes; Cell Death; Cell Hypoxia; Cell Line; Enzyme Activation; Guanidines; Imidazoles; JNK Mitogen-Activated Protein Kinases; MAP Kinase Kinase 4; Mitogen-Activated Protein Kinase Kinases; Molecular Structure; Myocardium; Nitriles; p38 Mitogen-Activated Protein Kinases; Pyrans; Pyridines; Reactive Oxygen Species

2004